TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer.

Barbara Melosky et al.PubMed ↗Publisher ↗

No numbers read from the abstract.